Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Total Liabilities (2022 - 2025)

NewGenIvf (NIVF) has disclosed Total Liabilities for 4 consecutive years, with $6.7 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 33.14% to $6.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.7 million through Dec 2025, up 33.14% year-over-year, with the annual reading at $6.7 million for FY2025, 33.14% up from the prior year.
  • Total Liabilities for Q4 2025 was $6.7 million at NewGenIvf, up from $5.1 million in the prior quarter.
  • The five-year high for Total Liabilities was $6.7 million in Q4 2025, with the low at $1.2 million in Q4 2023.
  • Average Total Liabilities over 4 years is $4.0 million, with a median of $3.9 million recorded in 2022.
  • The sharpest move saw Total Liabilities tumbled 55.73% in 2023, then skyrocketed 307.55% in 2024.
  • Over 4 years, Total Liabilities stood at $2.8 million in 2022, then crashed by 55.73% to $1.2 million in 2023, then skyrocketed by 307.55% to $5.1 million in 2024, then surged by 33.14% to $6.7 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $6.7 million, $5.1 million, and $1.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.